The company announced today that at LION’s Annual Meeting, the shareholders of LION bioscience approved with a majority of about 99 % of the eligible shares the actions taken by the actual members of the Management and Supervisory Board in the previous fiscal year. Furthermore, with the same majority the proposed changes of the Statutes were accepted as proposed and Ernst & Young AG was voted as the auditors for the current fiscal year.
